NEOVASC INC (NVCN) Stock Price, Quote, News and Overview
NASDAQ:NVCN - Nasdaq - CA64065J4037 - Common Stock - Currency: USD
NVCN Quote, Performance and Key Statistics
30.03
+0.49 (+1.66%)
The current stock price of NVCN is 30.03 USD. In the past month the price increased by 3.41%. In the past year, price increased by 212.49%.
NVCN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About NVCN
Company Profile
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures, and markets products for the cardiovascular marketplace. The firm is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The firm operates through one business segment: the development, manufacturing and marketing of medical devices. The firm's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The firm carries its business in Canada, the United States and Europe.
Company Info
NEOVASC INC
Richmond, 5138-13562 Maycrest Way
Richmond British Columbia BRITISH COLUMBIA V6V 2J7 CA
CEO: Fred Colen
Employees: 71
Company Website: https://www.neovasc.com/
Phone: 16042704344.0
NEOVASC INC / NVCN FAQ
What is the stock price of NEOVASC INC today?
The current stock price of NVCN is 30.03 USD. The price increased by 1.66% in the last trading session.
What is the ticker symbol for NEOVASC INC stock?
The exchange symbol of NEOVASC INC is NVCN and it is listed on the Nasdaq exchange.
On which exchange is NVCN stock listed?
NVCN stock is listed on the Nasdaq exchange.
What is NEOVASC INC worth?
NEOVASC INC (NVCN) has a market capitalization of 82.70M USD. This makes NVCN a Micro Cap stock.
How many employees does NEOVASC INC have?
NEOVASC INC (NVCN) currently has 71 employees.
What are the support and resistance levels for NEOVASC INC (NVCN) stock?
NEOVASC INC (NVCN) has a support level at 29.78 and a resistance level at 30.04. Check the full technical report for a detailed analysis of NVCN support and resistance levels.
Should I buy NEOVASC INC (NVCN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of NVCN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of NVCN, evaluating the profitability, health, valuation and growth aspects
- NEOVASC INC (NVCN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- NEOVASC INC (NVCN) Sales and EPS estimates to see what analysts future expectations are.
- NEOVASC INC (NVCN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- NEOVASC INC (NVCN) Insider and Institutional Ownership to learn about the owners and their transactions.
- NEOVASC INC (NVCN) Stock Chart to make your own analysis
- NEOVASC INC (NVCN) Latest news and press-releases to stay up to date.
Does NEOVASC INC (NVCN) stock pay dividends?
NVCN does not pay a dividend.
When does NEOVASC INC (NVCN) report earnings?
NEOVASC INC (NVCN) will report earnings on 2023-05-10, after the market close.
What is the Price/Earnings (PE) ratio of NEOVASC INC (NVCN)?
NEOVASC INC (NVCN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-105.01).
NVCN Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to NVCN. When comparing the yearly performance of all stocks, NVCN is one of the better performing stocks in the market, outperforming 99.36% of all stocks.
NVCN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NVCN. NVCN has a bad profitability rating. Also its financial health evaluation is rather negative.
NVCN Financial Highlights
Over the last trailing twelve months NVCN reported a non-GAAP Earnings per Share(EPS) of -105.01. The EPS decreased by -1143.35% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.81 |
NVCN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to NVCN. The Buy consensus is the average rating of analysts ratings from 7 analysts.